Skip to main content
Clinical Trials/JPRN-jRCTs051210028
JPRN-jRCTs051210028
Recruiting
Phase 2

A double-blind, randomized, controlled trial to evaluate the efficacy of carbon dioxide paste in patients after neck dissection

Hasegawa Takumi0 sites20 target enrollmentMay 24, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Hasegawa Takumi
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 24, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hasegawa Takumi

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients who are 20 years of age or older at informed consent
  • 2\.Patients with postoperative scarring pain after unilateral neck dissection
  • 3\.Patients from 6 months to 3 years after neck dissection
  • 4\.Patients with a VAS score of 1 or more but for neck pain
  • 5\.Patients who decide to participate in this clinical study by free will

Exclusion Criteria

  • 1\.Patients with drug sensitivity such as allergies
  • 2\.Patients with peripheral arterial disease and ischemia (Fontaine III \-IV), Patients with ischemic cerebral artery disease
  • 3\.Patients with heart failure and severe ischemic heart disease
  • 4\.Female patients who are pregnant, lactating, seeking to become pregnant within the study period, or who are unable to accept contraception
  • 5\.Patients with severe respiratory disease with SpO2: 90% or less
  • 6\.Patients who have difficulty applying the paste, such as those with skin ulcers or skin diseases larger than 4cm x 4cm x 1cm
  • 7\.Patients who are deemed inappropriate by the investigators of this clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials